An alternatively spliced soluble TNF-α receptor is associated with metabolic disorders A replication study

Clinical Immunology

Volumn 121, Issue 2, 2006, Pages 236-241

  Fernández Real, José Manuel ^a   Botas Cervero, Patricia ^b   Lainez, Begoña ^a   Ricart, Wifredo ^a   Delgado, Elías ^c  

^a HOSPITAL JOSEP TRUETA   (Spain)

^b HOSPITAL SAN AGUSTÍN   (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; URIC ACID;

ADULT; ALTERNATIVE RNA SPLICING; ARTICLE; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; IMMUNOASSAY; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC DISORDER; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RECEPTOR DENSITY;

ADULT; AGED; ALTERNATIVE SPLICING; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE INTOLERANCE; HUMANS; LONGITUDINAL STUDIES; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PROTEIN ISOFORMS; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 33750003733     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2006.07.011     Document Type: Article

References (35)

1. Ford E.S., Giles W.H., and Dietz W.H. Prevalence of the MS among US adults. Findings from the Third National Health and Nutrition Examination Survey. JAMA 287 (2002) 356-359
2. Vassalli P. The pathophysiology of tumor necrosis factors. Annu. Rev. Immunol. 10 (1992) 411-452
3. Tracey K.J., and Cerami A. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45 (1994) 491-503
4. Gamble J.R., Harlan J.M., Klebanoff S.J., and Vadas M.A. Stimulation of the adherence of neutrophils to umbilical vein endothelium by human recombinant tumor necrosis factor. Proc. Natl. Acad. Sci. U. S. A. 82 (1985) 8667-8671
5. Tartaglia L.A., and Goeddel D.V. Two TNF receptors. Immunol. Today 13 (1992) 151-153
6. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
7. Hotamisligil G.S., Peraldi P., Budavari A., Ellis R., White M.F., and Spiegelman B.M. IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science 271 (1996) 665-668
8. Kern P.A., Saghizadeh M., Ong J.M., Bosch R.J., Deem R., and Simsolo R.B. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight Loss, and relationship to lipoprotein lipase. J. Clin. Invest. 95 (1995) 2111-2119
9. Hotamisligil G.S., Arner P., Caro J.F., Atkinson R.L., and Spiegelman B.M. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95 (1995) 2409-2415
10. Saghizadeh M., Ong J.M., Garvey W.T., Henry R.R., and Kern P.A. The expression of TNFα by human muscle. Relationship to insulin resistance. J. Clin. Invest. 97 (1996) 1111-1116
11. Uysal K.T., Wiesbrock S.M., Marino M.W., and Hotamisligil G.S. Protection from obesity-induced insulin resistance in mice lacking TNF-α function. Nature 389 (1997) 610-614
12. Ventre J., Doebber T., Wu M., MacNaul K., Stevens K., Pasparakis M., Kollias G., and Moller D.E. Targeted disruption of the tumor necrosis factor-α gene. Metabolic consequences in obese and nonobese mice. Diabetes 46 (1997) 1526-1531
13. Schreyer S.A., Chua S.C., and LeBoeuf R.C. Obesity and diabetes in TNF-alfa receptor-deficient mice. J. Clin. Invest. 102 (1998) 402-411
14. Hofmann C., Lorenz K., Braithwaite S.S., Colca J.R., Palazuk B.J., Hotamisligil G.S., and Spiegelman B.M. Altered gene expression for tumor necrosis factor-alpha and its receptors during drug and dietary modulation of insulin resistance. Endocrinology 134 (1994) 264-270
15. Aderka D. The potential biological and clinical significance of the soluble tumor necrosis factor receptors. Cytokine Growth Factor Rev. 7 (1996) 231-240
16. Fernández-Real J.M., Broch M., Ricart W., Casamitjana R., Gutierrez C., Vendrell J., and Richart C. Plasma levels of the soluble fraction of tumor necrosis factor receptor 2 and insulin resistance. Diabetes 47 (1998) 1757-1762
17. Hotamisligil G.S., Arner P., Atkinson R.L., and Spiegelman B.M. Differential regulation of the p80 tumor necrosis factor receptor in human obesity and insulin resistance. Diabetes 46 (1997) 451-455
18. Hauner H., Bender M., Haastert B., and Hube F. Plasma concentrations of soluble TNF-alpha receptors in obese subjects. Int. J. Obes. Relat. Metab. Disord. 22 (1998) 1239-1243
19. Corica F., Allegra A., Corsonello A., Buemi M., Calapai G., Ruello A., Nicita Mauro V., and Ceruso D. Relationship between plasma leptin levels and the tumor necrosis factor-α system in obese subjects. Int. J. Obes. Relat Metab. Dis. 23 (1999) 355-360
20. Dzienis-Straczkowska S., Straczkowski M., Szelachowska M., Stepien A., Kowalska I., and Kinalska I. Soluble tumor necrosis factor-alpha receptors in young obese subjects with normal and impaired glucose tolerance. Diabetes Care 26 (2003) 875-880
21. Straczkowski M., Kowalska I., Stepien A., Dzienis-Straczkowska S., Szelachowska M., and Kinalska I. Increased plasma-soluble tumor necrosis factor-alpha receptor 2 level in lean nondiabetic offspring of type 2 diabetic subjects. Diabetes Care 25 (2002) 1824-1828
22. Straczkowski M., Kowalska I., Dzienis-Straczkowska S., Stepien A., Skibinska E., Szelachowska M., and Kinalska I. Changes in tumor necrosis factor-alpha system and insulin sensitivity during an exercise training program in obese women with normal and impaired glucose tolerance. Eur. J. Endocrinol. 145 (2001) 273-280
23. Fernández-Real J.M., and Ricart W. Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr. Rev. 24 (2003) 278-301
24. Fernández-Real J.M., Gutierrez C., Ricart W., Casamitjana R., Fernandez-Castaner M., Vendrell J., Richart C., and Soler J. The TNF-α Nco I polymorphism influences the relationship among insulin resistance, percent body fat and increased serum leptin levels. Diabetes 46 (1997) 1468-1472
25. Fernández-Real J.M., Vendrell J., Ricart W., Broch M., Gutierrez C., Casamitjana R., Oriola J., and Richart C. A Polymorphism of the tumor necrosis factor receptor-2 gene is associated with obesity, leptin levels and insulin resistance in young subjects and diet-treated type 2 diabetic patients. Diabetes Care 23 (2000) 831-837
26. Vendrell J., Fernández-Real J.M., Gutiérrez C., Zamora A., Simon I., Bardaji A., Ricart W., and Richart C. A polymorphism in the promoter of the TNF-alpha gene (- 308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167 (2003) 257-264
27. Laínez B., Fernández-Real J.M., Romero X., Esplugues E., Ricart W., and Engel P. Identification and expression of a spliced variant that encodes human soluble TNF type 2 receptor. Int. Immunol. 16 (2004) 169-177
28. Botas-Cervero P., Delgado-Alvarez E., Castano-Fernández G., Diaz De Grenu C., Prieto-Santiago J., and Diaz-Cadorniga F.J. Prevalence of diabetes mellitus and glucose intolerance in the population aged 30 to 75 years in Asturias, Spain. Rev. Clin. Esp. 202 (2002) 421-429
29. Fernández-Real J.M., Straczkowski M., Lainez B., Chacón M.R., Kowalska I., López-Bermejo A., García-España A., Nikolajuk A., Kinalska I., and Ricart W. An alternative spliced variant of circulating soluble TNF-α receptor-2 is paradoxically associated with insulin action. Eur. J. Endocrinol. 154 (2006) 723-730
30. Heaney M.L., and Golde D.W. Soluble receptors in human disease. J. Leukocyte Biol. 64 (1998) 135-146
31. Heaney M.L., and Golde D.W. Soluble cytokine receptors. Blood 87 (1996) 847-857
32. Rose-John S., and Heinrich P.C. Soluble receptors for cytokines and growth factors: generation and biological function. Biochem. J. 300 (1994) 281-290
33. Modrek B., Resch A., Grasso C., and Lee C. Genome-wide detection of alternative splicing in expressed sequences of human genes. Nucleic Acids Res. 29 (2001) 2850-2859
34. Michel J., Langstein J., Hofstadter F., and Schwarz H. A soluble form of CD137 (ILA/4-1BB), a member of the TNF receptor family, is released by activated lymphocytes and is detectable in sera of patients with rheumatoid arthritis. Eur. J. Immunol. 28 (1998) 290-295
35. Locksley R.M., Killeen N., and Lenardo M.J. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104 (2001) 487-501